Gunnar Olsson

Gunnar holds an MD and PhD in Medicine, Karolinska Institutet. 30-years of experience in life science, including 25 years in senior positions within AstraZeneca, among others in the management team for Global Cardiovascular and Gastrointestinal R&D as well as 10 years as leader for the same unit. Been responsible for the development and launch of six global blockbusters/mega brands.

Other ongoing assignments: Chair in Betagenon AB. Board member in Olsson Solutions AB, Gesynta Pharma AB and Hjärt-Lungfonden.

Shareholding: 4,000 Class A shares.